Body Mass Index (BMI) Requirements
Generally, BMI is one of the important indicators for assessing suitability for Tielborpeptide weight loss. It is typically suitable for overweight or obese individuals with a BMI reaching a certain value.
BMI ≥ 28 kg/m2 (Obese)
BMI > 24 kg/m2 (Overweight)
Patients with at least one weight-related comorbidity (such as hypertension, dyslipidemia, hyperglycemia, obstructive sleep apnea, cardiovascular disease, etc.) may be more suitable for considering Tielborpeptide for weight loss treatment.
Of course, it can also be used for individuals who are simply overweight without other significant comorbidities. The specific BMI value needs to be determined based on the individual's overall health condition and a comprehensive assessment by a doctor.
Health Condition Assessment
In addition to BMI, a comprehensive assessment of overall health condition is also required. Individuals with certain specific diseases or in special physiological states may not be suitable for use.